🇺🇸 Magnesium sulphate. in United States

468 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 468

Most-reported reactions

1. Premature Baby — 64 reports (13.68%)
2. Drug Ineffective — 62 reports (13.25%)
3. Foetal Exposure During Pregnancy — 62 reports (13.25%)
4. Death — 61 reports (13.03%)
5. Off Label Use — 48 reports (10.26%)
6. Nausea — 37 reports (7.91%)
7. Hypotension — 35 reports (7.48%)
8. Pyrexia — 34 reports (7.26%)
9. Maternal Exposure During Pregnancy — 33 reports (7.05%)
10. Low Birth Weight Baby — 32 reports (6.84%)

Source database →

Frequently asked questions

Is Magnesium sulphate. approved in United States?

Magnesium sulphate. does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Magnesium sulphate. in United States?

Ain Shams University is the originator. The local marketing authorisation holder may differ — check the official source linked above.